Sinopharm vaccine approval by the WHO; a step for breaking the monopoly of the West
Strategic Council Online—Interview: A university professor, while referring to the monopoly and profiteering aspects of some Western companies and countries especially the Europeans particularly in the production and distribution of the Covid-19 vaccines and related discriminations, said multinational pharmaceutical companies are seeking to preserve the current monopoly in manufacturing the Covid-19 vaccine however with the continuation of pressures by developing states against the intellectual property law, they may be able to produce their own national vaccines.
